Literature DB >> 12790521

Synthesis and characterization of an N-acylsulfonamide inhibitor of human asparagine synthetase.

Lukasz Koroniak1, Mihai Ciustea, Jemy A Gutierrez, Nigel G J Richards.   

Abstract

[structure: see text] The synthesis of N-acylsulfonamide 6, which is an analogue of beta-aspartyl-AMP, is described. This compound appears to be the first and only potent inhibitor of human asparagine synthetase that has been described to date. The N-acylsulfonamide 6 exhibits slow-onset inhibition kinetics, with a K(i) of 728 nM. Preparation and characterization of two additional N-acylsulfonamide analogues has also demonstrated the importance of hydrogen-bonding interactions in the recognition of the AS inhibitor with the enzyme. These observations provide the basis for the discovery of new compounds with application in the treatment of drug-resistant leukemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790521     DOI: 10.1021/ol034212n

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  13 in total

Review 1.  Asparagine synthetase chemotherapy.

Authors:  Nigel G J Richards; Michael S Kilberg
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

2.  An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

Authors:  Jemy A Gutierrez; Yuan-Xiang Pan; Lukasz Koroniak; Jun Hiratake; Michael S Kilberg; Nigel G J Richards
Journal:  Chem Biol       Date:  2006-12

3.  Stable analogues of OSB-AMP: potent inhibitors of MenE, the o-succinylbenzoate-CoA synthetase from bacterial menaquinone biosynthesis.

Authors:  Xuequan Lu; Rong Zhou; Indrajeet Sharma; Xiaokai Li; Gyanendra Kumar; Subramanyam Swaminathan; Peter J Tonge; Derek S Tan
Journal:  Chembiochem       Date:  2011-11-23       Impact factor: 3.164

4.  A conserved glutamate controls the commitment to acyl-adenylate formation in asparagine synthetase.

Authors:  Megan E Meyer; Jemy A Gutierrez; Frank M Raushel; Nigel G J Richards
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

5.  N-(Phenyl-sulfon-yl)-l-asparagine.

Authors:  Muhammad Nadeem Arshad; Hafiz Mubashar-Ur-Rehman; Islam Ullah Khan; Muhammad Shafiq; Kong Mun Lo
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-28

Review 6.  Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism.

Authors:  Nihed Draoui; Pauline de Zeeuw; Peter Carmeliet
Journal:  Open Biol       Date:  2017-12       Impact factor: 6.411

Review 7.  Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.

Authors:  Michaelyn C Lux; Lisa C Standke; Derek S Tan
Journal:  J Antibiot (Tokyo)       Date:  2019-04-15       Impact factor: 2.649

Review 8.  The Diverse Functions of Non-Essential Amino Acids in Cancer.

Authors:  Bo-Hyun Choi; Jonathan L Coloff
Journal:  Cancers (Basel)       Date:  2019-05-15       Impact factor: 6.639

9.  Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies.

Authors:  Alessandra Ammazzalorso; Simone Carradori; Andrea Angeli; Atilla Akdemir; Barbara De Filippis; Marialuigia Fantacuzzi; Letizia Giampietro; Cristina Maccallini; Rosa Amoroso; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

10.  Designed Small-Molecule Inhibitors of the Anthranilyl-CoA Synthetase PqsA Block Quinolone Biosynthesis in Pseudomonas aeruginosa.

Authors:  Cheng Ji; Indrajeet Sharma; Debarshi Pratihar; L Lynn Hudson; Damien Maura; Tezcan Guney; Laurence G Rahme; Everett C Pesci; James P Coleman; Derek S Tan
Journal:  ACS Chem Biol       Date:  2016-09-22       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.